VCI Global Receives a Huge Endorsement From a Large Institutional Investor
KUALA LUMPUR, Malaysia, April 22, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), […]
HeartCore Expands Partnership with Heart-Tech Health
NEW YORK and TOKYO, April 22, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading […]
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage […]
Emily Ansani Appointed to Board of Directors of NSTS Bancorp, Inc. and North Shore Trust and Savings
WAUKEGAN, Ill., April 22, 2024 (GLOBE NEWSWIRE) — NSTS Bancorp, Inc. (the “Company”), the holding company for North Shore Trust […]
Norwood Financial Corp Announces First Quarter 2024 Earnings
HONESDALE, Pa., April 22, 2024 (GLOBE NEWSWIRE) — James O. Donnelly, President and Chief Executive Officer of Norwood Financial Corp […]
trivago N.V.’s First Quarter 2024 Earnings Release Scheduled for April 30, 2024; Webcast Scheduled for May 1, 2024
DÜSSELDORF, GERMANY – April 22, 2024 – trivago N.V. (NASDAQ: TRVG) announced today that it will release its financial results […]
Sify reports Consolidated Financial Results for FY 2023-24
CHENNAI, India, April 22, 2024 (GLOBE NEWSWIRE) — EARNING CALLS DETAILS April 22, 2024| 8:30 AM ET Participant Dial in: […]
Amarin Announces Results of Annual General Meeting of Shareholders
DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of […]
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
Taiwan is ELEVAI’s third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in […]
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company […]
